Search Results - "STONE, GREGG W."

Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials by Costa, Francesco, MD, van Klaveren, David, MSc, James, Stefan, Prof, Heg, Dik, PhD, Räber, Lorenz, MD, Feres, Fausto, MD, Pilgrim, Thomas, MD, Hong, Myeong-Ki, Prof, Kim, Hyo-Soo, MD, Colombo, Antonio, MD, Steg, Philippe Gabriel, Prof, Zanchin, Thomas, MD, Palmerini, Tullio, MD, Wallentin, Lars, Prof, Bhatt, Deepak L, Prof, Stone, Gregg W, Prof, Windecker, Stephan, Prof, Steyerberg, Ewout W, Prof, Valgimigli, Marco, Prof

“…Summary Background Dual antiplatelet therapy (DAPT) with aspirin plus a P2Y12 inhibitor prevents ischaemic events after coronary stenting, but increases…”
Get full text

Intravascular Lithotripsy for Treatment of Severely Calcified Coronary Artery Disease by Hill, Jonathan M., Kereiakes, Dean J., Shlofmitz, Richard A., Klein, Andrew J., Riley, Robert F., Price, Matthew J., Herrmann, Howard C., Bachinsky, William, Waksman, Ron, Stone, Gregg W.

“…Coronary calcification hinders stent delivery and expansion and is associated with adverse outcomes. Intravascular lithotripsy (IVL) delivers acoustic pressure…”
Get full text

Trends and Outcomes of Restenosis After Coronary Stent Implantation in the United States by Moussa, Issam D., Mohananey, Divyanshu, Saucedo, Jorge, Stone, Gregg W., Yeh, Robert W., Kennedy, Kevin F., Waksman, Ron, Teirstein, Paul, Moses, Jeffrey W., Simonton, Chuck

“…There is a paucity of data on the burden of in-stent restenosis (ISR) in the United States as well as on its presentation and appropriate treatment strategies…”
Get full text

Relationship between microvascular obstruction and adverse events following primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: an individual patient data pooled analysis from seven randomized trials by de Waha, Suzanne, Patel, Manesh R, Granger, Christopher B, Ohman, E Magnus, Maehara, Akiko, Eitel, Ingo, Ben-Yehuda, Ori, Jenkins, Paul, Thiele, Holger, Stone, Gregg W

“…Microvascular obstruction (MVO) is the underlying cause for the no-reflow phenomenon in ST-segment elevation myocardial infarction (STEMI). The association…”
Get full text

Optimal duration of dual antiplatelet therapy after drug-eluting stent implantation: conceptual evolution based on emerging evidence by Palmerini, Tullio, Stone, Gregg W

“…The objective of this article is to review the contemporary literature on optimal dual antiplatelet therapy (DAPT) duration after drug-eluting stent (DES)…”
Get full text

Coronary Artery Disease in Patients ≥80 Years of Age by Madhavan, Mahesh V., Gersh, Bernard J., Alexander, Karen P., Granger, Christopher B., Stone, Gregg W.

“…Coronary artery disease (CAD) is a major cause of morbidity and mortality in patients ≥80 years of age. Nonetheless, older patients have typically been…”
Get full text

Efficacy and Safety of Dual Antiplatelet Therapy After Complex PCI by Giustino, Gennaro, MD, Chieffo, Alaide, MD, Palmerini, Tullio, MD, Valgimigli, Marco, MD, PhD, Feres, Fausto, MD, Abizaid, Alexandre, MD, Costa, Ricardo A., MD, Hong, Myeong-Ki, MD, PhD, Kim, Byeong-Keuk, MD, PhD, Jang, Yangsoo, MD, PhD, Kim, Hyo-Soo, MD, PhD, Park, Kyung Woo, MD, Gilard, Martine, MD, Morice, Marie-Claude, MD, Sawaya, Fadi, MD, Sardella, Gennaro, MD, Genereux, Philippe, MD, Redfors, Bjorn, MD, PhD, Leon, Martin B., MD, Bhatt, Deepak L., MD, MPH, Stone, Gregg W., MD, Colombo, Antonio, MD

“…Abstract Background Optimal upfront dual antiplatelet therapy (DAPT) duration after complex percutaneous coronary intervention (PCI) with drug-eluting stents…”
Get full text

Incidence, Predictors, and Impact of Post-Discharge Bleeding After Percutaneous Coronary Intervention by Généreux, Philippe, MD, Giustino, Gennaro, MD, Witzenbichler, Bernhard, MD, Weisz, Giora, MD, Stuckey, Thomas D., MD, Rinaldi, Michael J., MD, Neumann, Franz-Josef, MD, Metzger, D. Christopher, MD, Henry, Timothy D., MD, Cox, David A., MD, Duffy, Peter L., MD, MMM, Mazzaferri, Ernest, MD, Yadav, Mayank, MD, Francese, Dominic P., MPH, Palmerini, Tullio, MD, Kirtane, Ajay J., MD, SM, Litherland, Claire, MS, Mehran, Roxana, MD, Stone, Gregg W., MD

“…Abstract Background The incidence, predictors, and prognostic impact of post-discharge bleeding (PDB) after percutaneous coronary intervention (PCI) with…”
Get full text

Standardized End Point Definitions for Coronary Intervention Trials by Garcia-Garcia, Hector M, McFadden, Eugène P, Farb, Andrew, Mehran, Roxana, Stone, Gregg W, Spertus, John, Onuma, Yoshinobu, Morel, Marie-angèle, van Es, Gerrit-Anne, Zuckerman, Bram, Fearon, William F, Taggart, David, Kappetein, Arie-Pieter, Krucoff, Mitchell W, Vranckx, Pascal, Windecker, Stephan, Cutlip, Donald, Serruys, Patrick W

“…Abstract The Academic Research Consortium (ARC)-2 initiative revisited the clinical and angiographic end point definitions in coronary device trials, proposed…”
Get full text

Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study by Stone, Gregg W, Dr, Witzenbichler, Bernhard, MD, Weisz, Giora, MD, Rinaldi, Michael J, MD, Neumann, Franz-Josef, MD, Metzger, D Christopher, MD, Henry, Timothy D, MD, Cox, David A, MD, Duffy, Peter L, MD, Mazzaferri, Ernest, MD, Gurbel, Paul A, MD, Xu, Ke, PhD, Parise, Helen, MSc, Kirtane, Ajay J, MD, Brodie, Bruce R, MD, Mehran, Roxana, MD, Stuckey, Thomas D, MD

“…Summary Background The relation between platelet reactivity and stent thrombosis, major bleeding, and other adverse events after coronary artery implantation…”
Get full text

Updated Expert Consensus Statement on Platelet Function and Genetic Testing for Guiding P2Y12 Receptor Inhibitor Treatment in Percutaneous Coronary Intervention by Sibbing, Dirk, Aradi, Daniel, Alexopoulos, Dimitrios, ten Berg, Jurrien, Bhatt, Deepak L., Bonello, Laurent, Collet, Jean-Philippe, Cuisset, Thomas, Franchi, Francesco, Gross, Lisa, Gurbel, Paul, Jeong, Young-Hoon, Mehran, Roxana, Moliterno, David J., Neumann, Franz-Josef, Pereira, Naveen L., Price, Matthew J., Sabatine, Marc S., So, Derek Y.F., Stone, Gregg W., Storey, Robert F., Tantry, Udaya, Trenk, Dietmar, Valgimigli, Marco, Waksman, Ron, Angiolillo, Dominick J.

“…Dual-antiplatelet therapy (DAPT) with aspirin and a P2Y12 receptor inhibitor is the standard treatment for patients undergoing percutaneous coronary…”
Get full text

Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus Document by Garcia-Garcia, Hector M, McFadden, Eugène P, Farb, Andrew, Mehran, Roxana, Stone, Gregg W, Spertus, John, Onuma, Yoshinobu, Morel, Marie-angèle, van Es, Gerrit-Anne, Zuckerman, Bram, Fearon, William F, Taggart, David, Kappetein, Arie-Pieter, Krucoff, Mitchell W, Vranckx, Pascal, Windecker, Stephan, Cutlip, Donald, Serruys, Patrick W

“…The Academic Research Consortium (ARC)-2 initiative revisited the clinical and angiographic end point definitions in coronary device trials, proposed in 2007,…”
Get full text

Five-Year Follow-up after Transcatheter Repair of Secondary Mitral Regurgitation by Stone, Gregg W., Abraham, William T., Lindenfeld, JoAnn, Kar, Saibal, Grayburn, Paul A., Lim, D. Scott, Mishell, Jacob M., Whisenant, Brian, Rinaldi, Michael, Kapadia, Samir R., Rajagopal, Vivek, Sarembock, Ian J., Brieke, Andreas, Marx, Steven O., Cohen, David J., Asch, Federico M., Mack, Michael J.

“…Transcatheter repair of secondary mitral regurgitation was associated with a lower rate of hospitalization for heart failure and lower all-cause mortality than…”
Get full text

Bioresorbable Vascular Scaffolds for Coronary Revascularization by Kereiakes, Dean J, Onuma, Yoshinobu, Serruys, Patrick W, Stone, Gregg W

“…Contemporary metallic drug-eluting stents are associated with very good 1-year outcomes but an ongoing risk of stent-related adverse events (thrombosis,…”
Get full text

Dual Antiplatelet Therapy Duration Based on Ischemic and Bleeding Risks After Coronary Stenting by Costa, Francesco, Van Klaveren, David, Feres, Fausto, James, Stefan, Räber, Lorenz, Pilgrim, Thomas, Hong, Myeong-Ki, Kim, Hyo-Soo, Colombo, Antonio, Steg, Philippe Gabriel, Bhatt, Deepak L., Stone, Gregg W., Windecker, Stephan, Steyerberg, Ewout W., Valgimigli, Marco

“…Complex percutaneous coronary intervention (PCI) is associated with higher ischemic risk, which can be mitigated by long-term dual antiplatelet therapy (DAPT)…”
Get full text

Optical coherence tomography compared with intravascular ultrasound and with angiography to guide coronary stent implantation (ILUMIEN III: OPTIMIZE PCI): a randomised controlled trial by Ali, Ziad A, MD, Maehara, Akiko, MD, Généreux, Philippe, MD, Shlofmitz, Richard A, MD, Fabbiocchi, Franco, MD, Nazif, Tamim M, MD, Guagliumi, Giulio, MD, Meraj, Perwaiz M, MD, Alfonso, Fernando, MD, Samady, Habib, Prof, Akasaka, Takashi, Prof, Carlson, Eric B, MD, Leesar, Massoud A, Prof, Matsumura, Mitsuaki, BS, Ozan, Melek Ozgu, MS, Mintz, Gary S, MD, Ben-Yehuda, Ori, MD, Stone, Gregg W, Prof

“…Summary Background Percutaneous coronary intervention (PCI) is most commonly guided by angiography alone. Intravascular ultrasound (IVUS) guidance has been…”
Get full text

Mortality after drug-eluting stents vs. coronary artery bypass grafting for left main coronary artery disease: a meta-analysis of randomized controlled trials by Ahmad, Yousif, Howard, James P, Arnold, Ahran D, Cook, Christopher M, Prasad, Megha, Ali, Ziad A, Parikh, Manish A, Kosmidou, Ioanna, Francis, Darrel P, Moses, Jeffrey W, Leon, Martin B, Kirtane, Ajay J, Stone, Gregg W, Karmpaliotis, Dimitri

“…The optimal method of revascularization for patients with left main coronary artery disease (LMCAD) is controversial. Coronary artery bypass graft surgery…”
Get full text

Percutaneous Coronary Intervention for Vulnerable Coronary Atherosclerotic Plaque by Stone, Gregg W., Maehara, Akiko, Ali, Ziad A., Held, Claes, Matsumura, Mitsuaki, Kjøller-Hansen, Lars, Bøtker, Hans Erik, Maeng, Michael, Engstrøm, Thomas, Wiseth, Rune, Persson, Jonas, Trovik, Thor, Jensen, Ulf, James, Stefan K., Mintz, Gary S., Dressler, Ovidiu, Crowley, Aaron, Ben-Yehuda, Ori, Erlinge, David

“…Acute coronary syndromes most commonly arise from thrombosis of lipid-rich coronary atheromas that have large plaque burden despite angiographically appearing…”
Get full text

Long-Term Outcomes in Women and Men Following Percutaneous Coronary Intervention by Kosmidou, Ioanna, Leon, Martin B., Zhang, Yiran, Serruys, Patrick W., von Birgelen, Clemens, Smits, Pieter C., Ben-Yehuda, Ori, Redfors, Björn, Madhavan, Mahesh V., Maehara, Akiko, Mehran, Roxana, Stone, Gregg W.

“…Studies examining sex-related outcomes following percutaneous coronary intervention (PCI) have reported conflicting results. The purpose of this study was to…”
Get full text

Outcomes in the ISCHEMIA Trial Based on Coronary Artery Disease and Ischemia Severity by Reynolds, Harmony R., Shaw, Leslee J., Min, James K., Page, Courtney B., Berman, Daniel S., Chaitman, Bernard R., Picard, Michael H., Kwong, Raymond Y., O’Brien, Sean M., Huang, Zhen, Mark, Daniel B., Nath, Ranjit K., Dwivedi, Sudhanshu K., Smanio, Paola E.P., Stone, Peter H., Held, Claes, Keltai, Matyas, Bangalore, Sripal, Newman, Jonathan D., Spertus, John A., Stone, Gregg W., Maron, David J., Hochman, Judith S.

“…The ISCHEMIA trial (International Study of Comparative Health Effectiveness With Medical and Invasive Approaches) postulated that patients with stable coronary…”
Get full text